Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

Guidelines for the Standardization of Acute Graft-Versus-Host Disease Clinical Data Collection: An International Consensus Report

Blood (2015) 126 (23): 3154.

https://doi.org/10.1182/blood.V126.23.3154.3154

Published: 2015

Journal Articles

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Attaphol Pawarode, MD, Steven Goldstein, MD, Daniel R. Couriel, MD, Thomas Braun, PhD, John M. Magenau, MD, Mary Mansour Riwes, DO, Brian Parkin, Vedran Radojcic, MD, David Frame, PharmD, Sung Choi, MD, James Connelly, MD, John E. Levine, MD MS, Gregory A. Yanik, MD, Pavan Reddy, MD

Blood (2015) 126 (23): 1907.

https://doi.org/10.1182/blood.V126.23.1907.1907

Published: 2015

Journal Articles

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Rima M Saliba, PhD, Carrie Kitko, MD, Pavan Reddy, MD, John M. Magenau, MD, Attaphol Pawarode, Steven Goldstein, Daniel R. Couriel, MD

Blood (2014) 124 (21): 5875.

https://doi.org/10.1182/blood.V124.21.5875.5875

Published: 2014

Journal Articles

Peripheral Blood CD34 + Specific Donor Chimerism Analysis As an Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes and Acute Myelogenous Leukemia.

Maxim Norkin, MD, PhD, Amy Meacham, MS, Mai H Ta, MT, Neil Benson, MS, Steven Goldstein, MD, Emma Rosenau, MPH, Jack W. Hsu, MD, Christopher R. Cogle, MD, John W Hiemenz, MD, Randy A. Brown, MD, John R. Wingard, MD

Blood (2012) 120 (21): 3074.

https://doi.org/10.1182/blood.V120.21.3074.3074

Published: 2012

Journal Articles

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

Gregory A. Yanik, John M. Magenau, Shin Mineishi, Attaphol Pawarode, Keith Alangaden, Edward M. Peres, Steven Goldstein, John E. Levine, Sung Choi, Carrie L Kitko, Moshe Talpaz, MD, Daniel Couriel

Blood (2012) 120 (21): 3119.

https://doi.org/10.1182/blood.V120.21.3119.3119

Published: 2012

Journal Articles

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Andrew C. Harris, M.D., James L.M. Ferrara, M.D., D.Sc., Thomas M. Braun, Ph.D., Daniel R. Couriel, M.D., Sung W. Choi, M.D., Carrie Kitko, M.D., Steven Goldstein, John M. Magenau, M.D., Sophie Paczesny, M.D., Ph.D, Attaphol Pawarode, Pavan Reddy, M.D., Gregory A. Yanik, Austin Taylor, James Connelly, M.D., Craig A. Byersdorfer, M.D., Ph.D., John E. Levine, M.D., M.S.

Blood (2012) 120 (21): 463.

https://doi.org/10.1182/blood.V120.21.463.463

Published: 2012

Journal Articles

Outcomes of Myeloablative Hematopoietic Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia with Relapsed or Refractory Disease

Courtney D. DiNardo, MD, Alison Loren, MD, Steven Goldstein, MD, Stephen J. Schuster, Alexander Perl, MD, Donald Tsai, MD, Noelle Frey, MD, Elizabeth Hexner, MD, Ran Reshef, MD, Edward A. Stadtmauer, MD, David L. Porter, MD, Selina Luger, MD

Blood (2010) 116 (21): 2366.

https://doi.org/10.1182/blood.V116.21.2366.2366

Published: 2010

Journal Articles

A Comparison of Two Induction Regimens for Older Patients with Acute Lymphoblastic Leukemia: Daunorubicin, Vincristine and Prednisone (DVP) is Worth Considering

Daniel Landsburg, David Porter, Edward Stadtmauer, Alison Loren, Donald Tsai, Noelle Frey, Steven Goldstein, Elizabeth Hexner, Sunita Dwivedy Nasta, Alexander Perl, Jennifer Davis, Selina Luger

Blood (2010) 116 (21): 3252.

https://doi.org/10.1182/blood.V116.21.3252.3252

Published: 2010

Journal Articles

A Phase II Trial of Bexarotene, a Retinoid X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia

Donald E. Tsai, MD, PhD, Melissa Potuzak, BS, Anthony Mato, MD, Alison Wakoff Loren, MD, MS, David Porter, MD, Edward A. Stadtmauer, MD, Steven Goldstein, MD, Alexander Perl, MD, Cezary Swider, BS, Adam Bagg, MD, Emile Youssef, MD, PhD, Selina Luger, MD

Blood (2008) 112 (11): 4040.

https://doi.org/10.1182/blood.V112.11.4040.4040

Published: 2008

Journal Articles

Initial Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase I Clinical Trial of Systemic C-MYB Antisense Oligodeoxynucleotide in Subjects with Refractory Hematologic Malignancies

Noelle V Frey, Anna Kalota, Melissa Potuzak, Doris Shank, Cezary R Swider, Alison Loren, Edward Stadtmauer, Alexander Perl, Adam Cuker, Barbara Konkle, Suman Sood, Steven Goldstein, Margaret Kasner, David L Porter, Selina M Luger, Alan M Gewirtz

Blood (2008) 112 (11): 4033.

https://doi.org/10.1182/blood.V112.11.4033.4033

Published: 2008

Journal Articles

A Prospective Clinical Trial of a Novel Epstein-Barr Virus (EBV) PCR Panel in Patients with EBV Associated Malignancies.

Marin F. Xavier, MD, Dale Frank, MD, Sunita Nasta, MD, Stephen Schuster, MD, Charalambos Andreadis, MD, Sharon Arnoldi, Eric Sherman, MD, Sigrid Berg, MD, Anthony Mato, MD, Benjamin Musher, MD, Lisa Downs, David Porter, MD, Edward Stadtmauer, MD, Steven Goldstein, MD, Ellen Kim, MD, Donald Tsai, MD

Blood (2007) 110 (11): 2628.

https://doi.org/10.1182/blood.V110.11.2628.2628

Published: 2007

Journal Articles

A Phase I Trial of Bexarotene, a Retinoid X Receptor Agonist, in non-M3 Acute Myeloid Leukemia: Evidence of Myeloid Differentiation and Clinical Activity.

Donald E. Tsai, MD, PhD, Selina Luger, MD, Allison Kemner, RN, Alison W. Loren, MD, Cezary Swider, PhD, Ami Goradia, MD, Charalambos Andreadis, MD, Richard G. Ghalie, MD, James Thompson, MD, David Porter, MD, Edward A. Stadtmauer, MD, Stephen J. Schuster, MD, Alexander Perl, MD, Adam Bagg, MD, Steven Goldstein, MD, Martin Carroll, MD

Blood (2006) 108 (11): 1955.

https://doi.org/10.1182/blood.V108.11.1955.1955

Published: 2006

Journal Articles

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

David L. Porter, Bruce L. Levine, Nancy Bunin, Edward A. Stadtmauer, Selina M. Luger, Steven Goldstein, Alison Loren, Julie Phillips, Sunita Nasta, Alexander Perl, Steven Schuster, Donald Tsai, Ambika Sohal, Elizabeth Veloso, Stephen Emerson, Carl H. June

Blood (2006) 107 (4): 1325–1331.

https://doi.org/10.1182/blood-2005-08-3373

Published: 2006

Journal Articles

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Rebecca L. Olin, MD, David L. Porter, MD, Selina M. Luger, MD, Stephen J. Schuster, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Eli Glatstein, MD, Donald L. Siegel, MD, PhD, Dan T. Vogl, MD, Patricia Mangan, CRNP, Kathleen Cunningham, RN, BSN, Edward A. Stadtmauer, MD

Blood (2005) 106 (11): 1170.

https://doi.org/10.1182/blood.V106.11.1170.1170

Published: 2005

Journal Articles

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Elise A. Chong, Charalambos Andreadis, MD, Stephen J. Schuster, MD, Selina M. Luger, MD, David L. Porter, MD, Sunita Nasta, MD, Rebecca Elstrom, MD, Steven Goldstein, MD, Robert Sachs, MT, Lisa Downs, CRNP, Joel Green, Patricia A. Mangan, CRNP, Kimberly A. Hummel, Edward A. Stadtmauer, MD

Blood (2004) 104 (11): 5234.

https://doi.org/10.1182/blood.V104.11.5234.5234

Published: 2004

Journal Articles

Pegfilgrastim Versus Filgrastim To Accelerate Hematopoietic Recovery after High Dose Melphalan and Autologous Hematopoietic Stem Cell Transplant (ASCT) for Multiple Myeloma.

Rebecca L. Olin, MD, Selina M. Luger, MD, David L. Porter, MD, Stephen J. Schuster, MD, Donald Tsai, MD, Phd, Sunita Nasta, MD, Alexander Perl, MD, Alison W. Loren, MD, Steven Goldstein, MD, Patricia Mangan, CRNP, Vicki Sherry, CRNP, Kathleen Cunningham, RN, Bob Sachs, Kim Hummel, Edward A. Stadtmauer, MD

Blood (2004) 104 (11): 5193.

https://doi.org/10.1182/blood.V104.11.5193.5193

Published: 2004

Journal Articles

Utility of Prophylactic Autologous Stem Cell Collection for Patients with Acute Myeloid Leukemia in First Remission.

Margie Kasner, MD, Selina Luger, MD, Edward Stadtmauer, MD, Stephen Schuster, MD, Donald Tsai, MD, Sunita Nasta, MD, Alexander Perl, MD, Alison Loren, MD, Steven Goldstein, MD, Patricia Mangan, CRNP, Robert Sachs, Donald Seigel, MD, David Porter, MD

Blood (2004) 104 (11): 1872.

https://doi.org/10.1182/blood.V104.11.1872.1872

Published: 2004

Journal Articles

Age and Response after Autologous Stem Cell Transplantation (ASCT) Define a Group of Long-Term Event-Free Survivors among Patients (Pts) with Low-Grade Follicular Lymphoma (FL): A Single Institution Experience.

Charalambos Andreadis, MD, Elise A. Chong, Edward A. Stadtmauer, MD, Selina M. Luger, MD, David L. Porter, MD, Donald Tsai, MD, PhD, Sunita Nasta, MD, Rebecca Elstrom, MD, Steven Goldstein, MD, Lisa Downs, RN, Kathleen Cunningham, Kimberly Hummel, Stephen J. Schuster, MD

Blood (2004) 104 (11): 1883.

https://doi.org/10.1182/blood.V104.11.1883.1883

Published: 2004

Journal Articles

A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia.

Anthony R. Mato, MD, Brett E. Riccio, MD, Li Qin, PhD, Daniel Heitjan, PhD, Alison Loren, MD, Martin Carroll, MD, David Porter, MD, Donald Tsai, MD, Edward Stadtmauer, MD, Sasha Perl, MD, Alan Gewirtz, MD, Sunita Nasta, MD, Stephen Schuster, MD, Steven Goldstein, MD, Selina M. Luger, MD

Blood (2004) 104 (11): 883.

https://doi.org/10.1182/blood.V104.11.883.883

Published: 2004

Journal Articles

Enhancing Graft-vs-Tumor (GVT) Activity of Donor Leukocyte Infusions by Ex-Vivo Expansion and Activation with CD3/CD28 Co-Stimulation.

David Porter, MD, Bruce Levine, PhD, Nancy Bunin, MD, Edward Stadtmauer, MD, Selina Luger, MD, Steven Goldstein, MD, Stephen Schuster, MD, Donald Tsai, MD, Sunita Nasta, MD, Alison Loren, MD, Alexander Perl, MD, Julie Oliver, CRNP, Ambika Sohal, Liz Veloso, RN, Stephen Emerson, MD, PhD, Carl June, MD

Blood (2004) 104 (11): 1640.

https://doi.org/10.1182/blood.V104.11.1640.1640

Published: 2004

NARROW

Guidelines for the Standardization of Acute Graft-Versus-Host Disease Clinical Data Collection: An International Consensus Report

Phase 1 Study of Carfilzomib for the Prevention of Relapse and Graft-Versus-Host Disease in Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

Prognostic Value of TGFβ at Diagnosis of Chronic GvHD

Peripheral Blood CD34 + Specific Donor Chimerism Analysis As an Early Indicator of Disease Relapse After Allogeneic Hematopoietic Stem Cell Transplant in Patients with Myelodysplastic Syndromes and Acute Myelogenous Leukemia.

Unrelated Donor Transplants for Older AML Patients Using a Low Dose TBI Containing Regimen Are As Efficacious As Related Donor Transplants, and Exhibit Favorable Outcomes for Intermediate Risk Disease.

An Algorithm Combining Clinical Characteristics and Day 7 Biomarker Concentrations Predicts Future Graft-Versus-Host Disease Following Related Donor Hematopoietic Cell Transplantation

Outcomes of Myeloablative Hematopoietic Stem Cell Transplantation for Patients with Acute Myelogenous Leukemia with Relapsed or Refractory Disease

A Comparison of Two Induction Regimens for Older Patients with Acute Lymphoblastic Leukemia: Daunorubicin, Vincristine and Prednisone (DVP) is Worth Considering

A Phase II Trial of Bexarotene, a Retinoid X Receptor Agonist, in Non-M3 Acute Myeloid Leukemia

Initial Safety, Pharmacokinetic and Pharmacodynamic Data from a Phase I Clinical Trial of Systemic C-MYB Antisense Oligodeoxynucleotide in Subjects with Refractory Hematologic Malignancies

A Prospective Clinical Trial of a Novel Epstein-Barr Virus (EBV) PCR Panel in Patients with EBV Associated Malignancies.

A Phase I Trial of Bexarotene, a Retinoid X Receptor Agonist, in non-M3 Acute Myeloid Leukemia: Evidence of Myeloid Differentiation and Clinical Activity.

A phase 1 trial of donor lymphocyte infusions expanded and activated ex vivo via CD3/CD28 costimulation

Second Autologous Stem Cell Transplant (ASCT) as Salvage Therapy for Relapsed Multiple Myeloma.

Long Term Follow-Up of 4-Hydroperoxycyclophosphamide Purged Autologous Bone Marrow Transplantation in Non-Hodgkin’s Lymphoma Patients with High Risk of Bone Marrow Involvement.

Pegfilgrastim Versus Filgrastim To Accelerate Hematopoietic Recovery after High Dose Melphalan and Autologous Hematopoietic Stem Cell Transplant (ASCT) for Multiple Myeloma.

Utility of Prophylactic Autologous Stem Cell Collection for Patients with Acute Myeloid Leukemia in First Remission.

Age and Response after Autologous Stem Cell Transplantation (ASCT) Define a Group of Long-Term Event-Free Survivors among Patients (Pts) with Low-Grade Follicular Lymphoma (FL): A Single Institution Experience.

A Predictive Model for Tumor Lysis Syndrome in Acute Myelogenous Leukemia.

Enhancing Graft-vs-Tumor (GVT) Activity of Donor Leukocyte Infusions by Ex-Vivo Expansion and Activation with CD3/CD28 Co-Stimulation.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only